Delivery Order SPE2DB25D3201-SPE2DB25FNRDV

Award Date 2/18/25
Potential Completion Date 2/19/25
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,116.47 firm fixed-price delivery order is for the supply of Sulfamethoxazole-TMP DS tablets, with a completion date of August 15, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,308.83 firm fixed-price delivery order is for the supply of SULFAMETHOXAZOLE-TMP DS TABLET 100S, with a performance period running through January 17, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,206.02 firm fixed-price delivery order is for the supply of SULFAMETHOXAZOLE-TMP DS TABLET 100S, a generic pharmaceutical product. The contract has an ultimate completion date of December 23, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 100-count Sulfamethoxazole-TMP DS Tablets. The $1,060.67 firm-fixed-price delivery order has an ultimate completion date of August 7, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to $999,999,999 through December 2025, for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,835.30, is a Delivery Order for the supply of 4565133481 Sulfamethoxazole-TMP DS Tablets in 500-count packages. The contract has an ultimate completion date of July 15, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $1,011.38, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,688,728 units of Sulfamethoxazole-TMP DS Tablet 100s, a generic antimicrobial medication, with a completion date of December 12, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation indicated....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,457.09, is for the delivery of 100 count tablets of the pharmaceutical product Sulfamethoxazole-TMP DS. The contract is a firm fixed price delivery order, with a performance period ending on November 19, 2024. This award is not designated as a set-aside contract....
This federal contract award, valued at $1,771.94, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order for the supply of SULFAMETHOXAZOLE-TMP DS TABLET 500S, a pharmaceutical product, with a period of performance ending on February 20, 2025. The contract is not designated under any set-aside program. AmerisourceBergen holds a significant Indefinite...
This federal contract award, valued at $1,674.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4562800718 SULFAMETHOXAZOLE-TMP DS TABLET UD 100S, with a period of performance through November 14, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,813.15 firm fixed-price delivery order is for the supply of sulfamethoxazole-TMP DS tablets, with a period of performance through November 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
  • SPE2DB25D3201
    Indefinite Delivery Contract
  • SPE2DB25D3201-SPE2DB25FNRDV
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Sulfamethoxazole-TMP DS Tablets. The contract has a ceiling value of $1,875.62 and is a firm fixed-price delivery order with a completion date of February 19, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating open competition.

Generated 5/22/25, 8:13 PM